LifeVantage

LFVN · NASDAQ

$5.97+$0.0515 (+0.87%)TodayMarket closed ·
Prev close $5.92

Latest news

  • News

    12 Consumer Staples Stocks Moving In Thursday's After-Market Session

  • News

    Lifevantage Q4 2026 Earnings Call Transcript

  • News

    Lifevantage Q4 Adj. EPS $0.11 Misses $0.13 Estimate, Sales $42.377M Miss $45.949M Estimate

  • Press releaseGlobe Newswire

    LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

  • Press releaseGlobe Newswire

    LifeVantage Declares Quarterly Dividend

  • News

    12 Consumer Staples Stocks Moving In Monday's Pre-Market Session

  • NewsMohd Haider

    Why Did LifeVantage (LFVN) Stock Jump 27% After Hours?

  • News

    Earnings Scheduled For May 6, 2026

  • News

    Lifevantage Q3 Adj. EPS $0.11 Misses $0.16 Estimate, Sales $43.716M Miss $47.767M Estimate

  • Press releaseGlobe Newswire

    LifeVantage Declares Quarterly Dividend

  • Press releaseGlobe Newswire

    LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

  • Press releaseGlobe Newswire

    LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack

  • Press releaseGlobe Newswire

    LifeVantage to Participate in Water Tower Research Insights Conference on Wednesday, April 15, 2026

  • Press releaseGlobe Newswire

    LifeVantage Announces Expansion of its European Footprint with Market Opening in Portugal

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the Sidoti Small Cap Conference

  • Press releaseGlobe Newswire

    LifeVantage Declares Quarterly Dividend

  • Press releaseGlobe Newswire

    LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

  • Press releaseGlobe Newswire

    LifeVantage Kicked Off 2026 With Global Kickoff, a Virtual Event Showcasing Innovation and Integration

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the 28th Annual ICR Conference

  • Press releaseGlobe Newswire

    New Study Finds LifeVantage's P84 Positively Impacts Gut Peptide Production, Activating Key Elements for Comprehensive Gut Health

  • Press releaseGlobe Newswire

    LifeVantage Declares Quarterly Dividend

  • Press releaseGlobe Newswire

    LifeVantage Announces Financial Results for the First Quarter of Fiscal 2026

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the LD Micro Main Event XIX on October 20, 2025

  • Press releaseGlobe Newswire

    LifeVantage Announces Closing of LoveBiome Acquisition

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025

  • NewsAvi Kapoor

    American Outdoor Brands Posts Downbeat Results, Joins Lululemon, Quanex Building And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • NewsAvi Kapoor

    Why Docusign Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

  • Press releaseGlobe Newswire

    LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025

  • News

    LifeVantage Acquires LoveBiome; Terms Not Disclosed

  • Press releaseGlobe Newswire

    LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

  • Press releaseGlobe Newswire

    LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System™; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡

  • Press releaseGlobe Newswire

    LifeVantage Expands Global Reach with International Launch of the MB System™

  • News

    Earnings Scheduled For February 5, 2025

  • News

    LifeVantage Announces Completion Of Study On MindBody GLP-1 System. The Study Focused On L-Cells And Key Genes In GLP-1 Production Using ELISA And Fluorescent Microscopy

  • Press releaseGlobe Newswire

    LifeVantage Announces Completion of International In Vitro Study on the MB System™

  • Press releaseGlobe Newswire

    LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the 27th Annual ICR Conference

  • News

    "Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the Water Tower Fireside Chat Series

  • Press releaseGlobe Newswire

    LifeVantage to Participate at the Sidoti Micro Cap Conference

  • Press releaseGlobe Newswire

    LifeVantage to Participate at the LD Micro Main Event XVII

  • News

    Market-Moving News for October 14th

  • Press releaseGlobe Newswire

    LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.